Main Street Research’s Abeona Therapeutics ABEO Stock Holding History

Main Street Research’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$238K	Buy	+38,514	New	+$211K	0.01%	132

Other funds holding ABEO

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Aries Wealth Management Portland, Maine $509M AUM 25.6% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Allied Private Wealth Boca Raton, Florida $156M AUM

Main Street Research's ABEO Position: Q2 2026 in Review

Main Street Research opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 38,514 shares worth $238K. The stake represents 0.01% of the portfolio and ranks #132 among its holdings.

20 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Main Street Research held 38,514 shares of Abeona Therapeutics worth $238K as of Q2 2026.
Abeona Therapeutics was a new Main Street Research position in Q2 2026.
Abeona Therapeutics made up 0.01% of Main Street Research's portfolio in Q2 2026, its #132 holding.
20 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Main Street Research's 13F filing for Q2 2026, filed 29 Jul 2026.